Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linna Wang

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Journal of Hematology & Oncology|May 13, 2020
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trialFeng Wang, Shukui Qin, Xinchen Sun, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 13, 2023
Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In VivoYueping Zhang, Petia A Shipkova, Bethanne M Warrack, et al.
Pharmacological Research|June 15, 2025
TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearanceYuping Wang, Weidan Luo, Wanyu Wu, et al.
Pharmacological Research|January 13, 2026
Corrigendum to "TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance" [Pharmacol. Res. 218 (2025) 107817]Yuping Wang, Weidan Luo, Wanyu Wu, et al.
Pharmacological Research|August 16, 2023
Tricin promoted ATG-7 dependent autophagic degradation of α-synuclein and dopamine release for improving cognitive and motor deficits in Parkinson's diseaseXingxia Wang, Wei Hu, Liqun Qu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 11, 2025
Anxiolytic effects of corilagin by targeting Htr2c through activation of the TrkB/CREB/BDNF pathwayXiaoyun Yun, Jianhui Wu, Jie Zhou, et al.
Ebiomedicine|June 9, 2026
The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic interventionQiao Yin, Mengyang Ding, Yurui Tang, et al.
Oncogene|February 12, 2020
Cancer cell-intrinsic function of CD177 in attenuating β-catenin signalingPaige N Kluz, Ryan Kolb, Qing Xie, et al.
BMC Medicine|October 25, 2022
Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trialDan Liu, Jun Zhou, Yongsheng Wang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 7, 2023
Mutant p53<sup>R211*</sup> ameliorates inflammatory arthritis in AIA rats via inhibition of TBK1-IRF3 innate immune responseYaling Zeng, Jerome P L Ng, Linna Wang, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Journal of Hematology & Oncology|May 13, 2020
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trialFeng Wang, Shukui Qin, Xinchen Sun, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 13, 2023
Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In VivoYueping Zhang, Petia A Shipkova, Bethanne M Warrack, et al.
Pharmacological Research|June 15, 2025
TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearanceYuping Wang, Weidan Luo, Wanyu Wu, et al.
Pharmacological Research|January 13, 2026
Corrigendum to "TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance" [Pharmacol. Res. 218 (2025) 107817]Yuping Wang, Weidan Luo, Wanyu Wu, et al.
Pharmacological Research|August 16, 2023
Tricin promoted ATG-7 dependent autophagic degradation of α-synuclein and dopamine release for improving cognitive and motor deficits in Parkinson's diseaseXingxia Wang, Wei Hu, Liqun Qu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 11, 2025
Anxiolytic effects of corilagin by targeting Htr2c through activation of the TrkB/CREB/BDNF pathwayXiaoyun Yun, Jianhui Wu, Jie Zhou, et al.
Ebiomedicine|June 9, 2026
The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic interventionQiao Yin, Mengyang Ding, Yurui Tang, et al.
Oncogene|February 12, 2020
Cancer cell-intrinsic function of CD177 in attenuating β-catenin signalingPaige N Kluz, Ryan Kolb, Qing Xie, et al.
BMC Medicine|October 25, 2022
Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trialDan Liu, Jun Zhou, Yongsheng Wang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 7, 2023
Mutant p53<sup>R211*</sup> ameliorates inflammatory arthritis in AIA rats via inhibition of TBK1-IRF3 innate immune responseYaling Zeng, Jerome P L Ng, Linna Wang, et al.
Pageof 16